Ispecimen INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
ISPC
Ispecimen INCiSpecimen Inc. disclosed a 79% revenue drop and continued net losses in its 2025 annual report, alongside significant cost reductions and ongoing legal challenges, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
ISPC
Ispecimen INCiSpecimen Inc.'s annual report reveals a net loss of $12.5 million for 2024 and raises substantial doubt about the company's ability to continue as a going concern.
NASDAQ
ISPC
Ispecimen INCiSpecimen Inc.'s 2023 annual report reveals a net loss of $11.1 million and a material weakness in internal controls, alongside efforts to enhance its marketplace platform and address financial challenges.